- Home
- CCCC vs MGF Comparison
CCCC vs MGF Comparison
Compare CCCC & MGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- MGF
- Stock Information
- Founded
- CCCC 2015
- MGF 1987
- Country
- CCCC United States
- MGF United States
- Employees
- CCCC N/A
- MGF N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- MGF Trusts Except Educational Religious and Charitable
- Sector
- CCCC Health Care
- MGF Finance
- Exchange
- CCCC Nasdaq
- MGF Nasdaq
- Market Cap
- CCCC 115.0M
- MGF 100.4M
- IPO Year
- CCCC 2020
- MGF N/A
- Fundamental
- Price
- CCCC $1.50
- MGF $3.05
- Analyst Decision
- CCCC Buy
- MGF
- Analyst Count
- CCCC 4
- MGF 0
- Target Price
- CCCC $12.50
- MGF N/A
- AVG Volume (30 Days)
- CCCC 1.3M
- MGF 104.4K
- Earning Date
- CCCC 05-07-2025
- MGF 01-01-0001
- Dividend Yield
- CCCC N/A
- MGF 7.64%
- EPS Growth
- CCCC N/A
- MGF N/A
- EPS
- CCCC N/A
- MGF N/A
- Revenue
- CCCC $39,783,000.00
- MGF N/A
- Revenue This Year
- CCCC N/A
- MGF N/A
- Revenue Next Year
- CCCC $36.31
- MGF N/A
- P/E Ratio
- CCCC N/A
- MGF N/A
- Revenue Growth
- CCCC 98.56
- MGF N/A
- 52 Week Low
- CCCC $1.09
- MGF $2.91
- 52 Week High
- CCCC $7.66
- MGF $3.46
- Technical
- Relative Strength Index (RSI)
- CCCC 46.32
- MGF 40.81
- Support Level
- CCCC $1.42
- MGF $3.06
- Resistance Level
- CCCC $1.64
- MGF $3.12
- Average True Range (ATR)
- CCCC 0.15
- MGF 0.03
- MACD
- CCCC 0.02
- MGF -0.00
- Stochastic Oscillator
- CCCC 25.64
- MGF 0.00
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About MGF MFS Government Markets Income Trust
MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.